药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Colistin
Nilotinib
The metabolism of Nilotinib can be decreased when combined with Idarubicin.
Colistin
Peruvoside
Peruvoside may decrease the cardiotoxic activities of Idarubicin.
Colistin
Acetyldigoxin
Acetyldigoxin may decrease the cardiotoxic activities of Idarubicin.
Colistin
Gitoformate
Gitoformate may decrease the cardiotoxic activities of Idarubicin.
Colistin
Lanatoside C
Lanatoside C may decrease the cardiotoxic activities of Idarubicin.
Colistin
Metildigoxin
Metildigoxin may decrease the cardiotoxic activities of Idarubicin.
Colistin
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Idarubicin.
Colistin
Cymarin
Cymarin may decrease the cardiotoxic activities of Idarubicin.
Colistin
Oleandrin
Oleandrin may decrease the cardiotoxic activities of Idarubicin.
Colistin
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Idarubicin.
Colistin
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Idarubicin.
Colistin
Fingolimod
Idarubicin may increase the immunosuppressive activities of Fingolimod.
Colistin
Tofacitinib
Idarubicin may increase the immunosuppressive activities of Tofacitinib.
Colistin
Metamizole
The risk or severity of myelosuppression can be increased when Metamizole is combined with Idarubicin.
Colistin
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Idarubicin.
Colistin
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Idarubicin.
Colistin
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Idarubicin.
Colistin
Roflumilast
Roflumilast may increase the immunosuppressive activities of Idarubicin.
Colistin
Difluocortolone
The risk or severity of adverse effects can be increased when Idarubicin is combined with Difluocortolone.
Colistin
Clobetasol
The risk or severity of adverse effects can be increased when Idarubicin is combined with Clobetasol.